Tech Company Financing Transactions

Tarveda Therapeutics Funding Round

On 1/27/2016, Tarveda Therapeutics raised $38 million in Series C investment from New Enterprise Associates, Novo Ventures and Eminent Venture Capital.

Transaction Overview

Company Name
Tarveda Therapeutics
Announced On
1/27/2016
Transaction Type
Venture Equity
Amount
$38,000,000
Round
Series C
Investors

New Enterprise Associates (Lead Investor) (Frank Torti)

Novo Ventures (Lead Investor) (Nilesh Kumar)

Eminent Venture Capital

Flagship Pioneering (Ed Kania)

NanoDimension

Proceeds Purpose
Proceeds from the Series C financing will be used to advance a pipeline of Pentarins that Tarveda is developing for a range of solid tumor targets. In particular, the funding will support the advancement of Tarveda's lead drug candidate, PEN-221, into Phase 1 clinical studies in mid-2016. PEN-221 is designed to target the somatostatin receptor for treatment of patients with neuroendocrine cancers including small cell lung cancer.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
134 Coolidge Avenue
Watertown, MA 02472
USA
Phone
(617) 923-4100
Website
www.tarvedatx.com
Email Address
[email protected]
Overview
Tarveda creates Pentarins that are targeted miniature drug conjugates that remain miniature by design to overcome the challenges that limit the efficacy of larger antibody drug conjugates in use and development today.
Profile
Tarveda Therapeutics LinkedIn Company Profile
Social Media
Tarveda Therapeutics Company Twitter Account
Company News
Tarveda Therapeutics News
Facebook
Tarveda Therapeutics on Facebook
YouTube
Tarveda Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Drew Fromkin
  Drew Fromkin LinkedIn Profile  Drew Fromkin Twitter Account  Drew Fromkin News  Drew Fromkin on Facebook
Chief Medical Officer
Leila Alland
  Leila Alland LinkedIn Profile  Leila Alland Twitter Account  Leila Alland News  Leila Alland on Facebook
VP - Bus. Development
Sudha Kadiyala
  Sudha Kadiyala LinkedIn Profile  Sudha Kadiyala Twitter Account  Sudha Kadiyala News  Sudha Kadiyala on Facebook
VP - R & D
Richard Wooster
  Richard Wooster LinkedIn Profile  Richard Wooster Twitter Account  Richard Wooster News  Richard Wooster on Facebook

 

 

Browse more venture capital transactions:

Prev: 1/27/2016: 360insights venture capital transaction
Next: 1/27/2016: icejam games venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We do our best to report on funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.